HRP20160127T1 - Biomarkeri raka pluä†a i njihove uporabe - Google Patents
Biomarkeri raka pluä†a i njihove uporabe Download PDFInfo
- Publication number
- HRP20160127T1 HRP20160127T1 HRP20160127TT HRP20160127T HRP20160127T1 HR P20160127 T1 HRP20160127 T1 HR P20160127T1 HR P20160127T T HRP20160127T T HR P20160127TT HR P20160127 T HRP20160127 T HR P20160127T HR P20160127 T1 HRP20160127 T1 HR P20160127T1
- Authority
- HR
- Croatia
- Prior art keywords
- individual
- biomarker
- biomarkers
- biological sample
- lung cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Organic Chemistry (AREA)
- Mathematical Physics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Pure & Applied Mathematics (AREA)
- Algebra (AREA)
- Biophysics (AREA)
- Mathematical Analysis (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Computational Mathematics (AREA)
- Mathematical Optimization (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9559308P | 2008-09-09 | 2008-09-09 | |
| US15283709P | 2009-02-16 | 2009-02-16 | |
| PCT/US2009/056399 WO2010030697A1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
| EP09813557.7A EP2340506B1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160127T1 true HRP20160127T1 (hr) | 2016-03-11 |
Family
ID=42005456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160127TT HRP20160127T1 (hr) | 2008-09-09 | 2009-09-09 | Biomarkeri raka pluä†a i njihove uporabe |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2340506B1 (enExample) |
| JP (1) | JP5701212B2 (enExample) |
| KR (1) | KR101658347B1 (enExample) |
| CN (2) | CN104198709A (enExample) |
| AU (2) | AU2009291811B2 (enExample) |
| CA (3) | CA3011730C (enExample) |
| DK (1) | DK2340506T3 (enExample) |
| ES (1) | ES2559758T3 (enExample) |
| GB (1) | GB2478441B (enExample) |
| HK (1) | HK1204062A1 (enExample) |
| HR (1) | HRP20160127T1 (enExample) |
| MX (1) | MX2011002322A (enExample) |
| SI (1) | SI2340506T1 (enExample) |
| WO (1) | WO2010030697A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| ES2703714T3 (es) | 2009-03-12 | 2019-03-12 | Cancer Prevention & Cure Ltd | Métodos de identificación, evaluación, prevención y terapia de enfermedades pulmonares y kits de los mismos, incluida la identificación, evaluación, prevención y terapia de enfermedades en base al género |
| CA2801110C (en) * | 2010-07-09 | 2021-10-05 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN106198980B (zh) | 2010-08-13 | 2018-09-07 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| RU2612017C2 (ru) * | 2011-04-07 | 2017-03-01 | Де Скриппс Рисерч Инститьют | Высокопроизводительный скрининг соединений, модулирующих экспрессию клеточных макромолекул |
| EP2702411A4 (en) * | 2011-04-29 | 2015-07-22 | Cancer Prevention & Cure Ltd | METHOD FOR IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREFOR |
| JP5986638B2 (ja) * | 2011-10-24 | 2016-09-06 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーおよびその使用 |
| CA2860298A1 (en) | 2011-12-21 | 2013-06-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US9304137B2 (en) | 2011-12-21 | 2016-04-05 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US11913957B2 (en) | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| EP2815343A2 (en) * | 2012-02-17 | 2014-12-24 | Koninklijke Philips N.V. | Acute lung injury (ali)/acute respiratory distress syndrome (ards) assessment and monitoring |
| CN104812913B (zh) | 2012-11-07 | 2019-03-15 | 私募蛋白质体公司 | 慢性阻塞性肺疾病(copd)生物标记及其用途 |
| BR112016010322A2 (pt) * | 2013-11-07 | 2017-08-08 | Medial Res Ltd | Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão |
| JP6857185B2 (ja) * | 2015-09-11 | 2021-04-14 | アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法 |
| FR3050269B1 (fr) | 2016-04-15 | 2018-05-11 | Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) | Procede de selection et de recuperation de produits et systeme associe |
| CN105823665A (zh) * | 2016-05-13 | 2016-08-03 | 北京九州柏林生物科技有限公司 | 生物组织样本制备套液 |
| CA3026809A1 (en) | 2016-06-21 | 2017-12-28 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| CN110709936A (zh) | 2017-04-04 | 2020-01-17 | 肺癌蛋白质组学有限责任公司 | 用于早期肺癌预后的基于血浆的蛋白质概况分析 |
| EP3676393A4 (en) | 2017-09-01 | 2021-10-13 | Venn Biosciences Corporation | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING |
| US11885815B2 (en) * | 2017-11-22 | 2024-01-30 | Gritstone Bio, Inc. | Reducing junction epitope presentation for neoantigens |
| EP3728630A4 (en) | 2017-12-19 | 2021-11-17 | The Wistar Institute Of Anatomy And Biology | COMPOSITIONS AND METHODS OF DIAGNOSING LUNG CANCER USING GENE EXPRESSION PROFILES |
| JP7526102B2 (ja) * | 2018-06-22 | 2024-07-31 | ソマロジック・オペレイティング・カンパニー・インコーポレイテッド | 改良されたプロテオミクスマルチプレックスアッセイ |
| WO2020256640A1 (en) * | 2019-06-21 | 2020-12-24 | National University Of Singapore | Methods for determining the likelihood of lung cancer |
| CN110579611B (zh) * | 2019-09-18 | 2023-01-31 | 郑州大学 | 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法 |
| CN111047609B (zh) * | 2020-03-13 | 2020-07-24 | 北京深睿博联科技有限责任公司 | 肺炎病灶分割方法和装置 |
| CN113960235B (zh) * | 2020-10-10 | 2023-03-14 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 生物标志物在制备肺癌检测试剂中的用途和方法 |
| CN112557514B (zh) * | 2020-12-22 | 2021-09-21 | 中国海洋大学 | 手持式海底沉积物样品剖面声学全自动测量装置 |
| WO2025137139A1 (en) * | 2023-12-18 | 2025-06-26 | Caris Mpi, Inc. | Dynamic tissue typing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596503B1 (en) * | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| EP1373896A2 (en) * | 2001-03-12 | 2004-01-02 | MonoGen, Inc. | Cell-based detection and differentiation of disease states |
| JP2005527180A (ja) * | 2001-04-18 | 2005-09-15 | プロテイン デザイン ラブス， インコーポレイテッド | 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法 |
| WO2004061410A2 (en) * | 2002-12-18 | 2004-07-22 | Ciphergen Biosystems, Inc. | Serum biomarkers in lung cancer |
| CN1225477C (zh) * | 2003-03-28 | 2005-11-02 | 上海市疾病预防控制中心 | 肺癌早期血清特异蛋白及其应用 |
| CN1455257A (zh) * | 2003-05-23 | 2003-11-12 | 北京师范大学 | 一种利用表面修饰蛋白芯片进行肺癌诊断方法 |
| TW200600785A (en) * | 2004-03-23 | 2006-01-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancer |
| JP2005304497A (ja) * | 2004-03-25 | 2005-11-04 | Joji Inasawa | 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法 |
| JP4885122B2 (ja) * | 2004-04-15 | 2012-02-29 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 癌、器官傷害、および筋肉リハビリテーション／運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー |
| WO2005103281A2 (en) * | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| KR20070043868A (ko) * | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | 암에 대한 혈소판 바이오마커 |
| CN1873417A (zh) * | 2005-06-02 | 2006-12-06 | 中国医学科学院肿瘤医院肿瘤研究所 | 一种用于诊断肺癌的蛋白质芯片 |
| EP3153860A3 (en) * | 2005-12-22 | 2017-06-14 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US7908091B2 (en) * | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| AU2007313551A1 (en) * | 2006-10-17 | 2008-04-24 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| US20110119776A1 (en) * | 2007-02-05 | 2011-05-19 | Wong Kwok-Kin | Methods of diagnosing and prognosing lung cancer |
| KR100846354B1 (ko) * | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| US20100184773A1 (en) * | 2007-05-18 | 2010-07-22 | Heinz-Josef Lenz | Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy |
| WO2009036123A1 (en) * | 2007-09-11 | 2009-03-19 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| WO2010003772A1 (en) * | 2008-06-16 | 2010-01-14 | Siemens Medical Solutions Diagnostics Gmbh | Method for predicting adverse response to erythropoietin in breast cancer treatment |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN102906275A (zh) * | 2010-02-10 | 2013-01-30 | 加利福尼亚大学董事会 | 肺癌检测的唾液生物标记 |
-
2009
- 2009-09-09 SI SI200931363T patent/SI2340506T1/sl unknown
- 2009-09-09 CA CA3011730A patent/CA3011730C/en active Active
- 2009-09-09 EP EP09813557.7A patent/EP2340506B1/en active Active
- 2009-09-09 JP JP2011526308A patent/JP5701212B2/ja active Active
- 2009-09-09 CA CA2734535A patent/CA2734535C/en active Active
- 2009-09-09 CN CN201410477840.7A patent/CN104198709A/zh active Pending
- 2009-09-09 AU AU2009291811A patent/AU2009291811B2/en active Active
- 2009-09-09 DK DK09813557.7T patent/DK2340506T3/en active
- 2009-09-09 WO PCT/US2009/056399 patent/WO2010030697A1/en not_active Ceased
- 2009-09-09 CA CA3152591A patent/CA3152591C/en active Active
- 2009-09-09 HR HRP20160127TT patent/HRP20160127T1/hr unknown
- 2009-09-09 GB GB1106053.0A patent/GB2478441B/en active Active
- 2009-09-09 MX MX2011002322A patent/MX2011002322A/es active IP Right Grant
- 2009-09-09 CN CN200980144620.XA patent/CN102209968B/zh active Active
- 2009-09-09 ES ES09813557.7T patent/ES2559758T3/es active Active
- 2009-09-09 KR KR1020117005305A patent/KR101658347B1/ko active Active
-
2015
- 2015-05-18 HK HK15104677.5A patent/HK1204062A1/xx unknown
- 2015-10-29 AU AU2015249113A patent/AU2015249113B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2340506A4 (en) | 2012-02-15 |
| WO2010030697A1 (en) | 2010-03-18 |
| HK1153834A1 (en) | 2012-04-05 |
| GB201106053D0 (en) | 2011-05-25 |
| CN104198709A (zh) | 2014-12-10 |
| CA3152591A1 (en) | 2010-03-18 |
| KR101658347B1 (ko) | 2016-09-21 |
| MX2011002322A (es) | 2011-05-10 |
| KR20110063753A (ko) | 2011-06-14 |
| CN102209968B (zh) | 2016-05-04 |
| AU2015249113A1 (en) | 2015-11-12 |
| CA3011730A1 (en) | 2010-03-18 |
| AU2009291811B2 (en) | 2015-10-29 |
| AU2009291811A1 (en) | 2010-03-18 |
| HK1204062A1 (en) | 2015-11-06 |
| EP2340506A1 (en) | 2011-07-06 |
| CA3152591C (en) | 2023-08-29 |
| ES2559758T3 (es) | 2016-02-15 |
| GB2478441A (en) | 2011-09-07 |
| JP5701212B2 (ja) | 2015-04-15 |
| CA3011730C (en) | 2022-05-17 |
| GB2478441B (en) | 2013-03-27 |
| SI2340506T1 (sl) | 2016-02-29 |
| DK2340506T3 (en) | 2016-02-08 |
| JP2012502281A (ja) | 2012-01-26 |
| EP2340506B1 (en) | 2015-11-11 |
| CA2734535A1 (en) | 2010-03-18 |
| CN102209968A (zh) | 2011-10-05 |
| CA2734535C (en) | 2018-08-28 |
| AU2015249113B2 (en) | 2017-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160127T1 (hr) | Biomarkeri raka pluä†a i njihove uporabe | |
| Dayon et al. | Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications | |
| Haselbeck et al. | Serology as a tool to assess infectious disease landscapes and guide public health policy | |
| Mischak et al. | Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience | |
| JP2012502281A5 (enExample) | ||
| Cota et al. | Diagnostic performance of commercially available COVID-19 serology tests in Brazil | |
| McDougal et al. | Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries | |
| JP7680950B2 (ja) | 生存分析によるクラス不均衡セットのダウンサンプリングを組み合わせた疾患リスクを判定するための方法 | |
| Morelli et al. | The common cuckoo is an effective indicator of high bird species richness in Asia and Europe | |
| US20200188907A1 (en) | Marker analysis for quality control and disease detection | |
| Schneider et al. | The utility of differential scanning calorimetry curves of blood plasma for diagnosis, subtype differentiation and predicted survival in lung cancer | |
| CN117092343A (zh) | 一种用于检测人体免疫年龄的试剂盒以及人体免疫年龄确定方法、装置、系统和存储介质 | |
| Cox et al. | Comparative evaluation of Luminex based assays for detection of SARS-CoV-2 antibodies in a transplantation laboratory | |
| CN113393902A (zh) | 基于免疫表征技术对样本分类的方法、装置及存储介质 | |
| JP2006508326A5 (enExample) | ||
| Ioannidis | A roadmap for successful applications of clinical proteomics | |
| Zhang et al. | Tracing human life trajectory using gut microbial communities by context-aware deep learning | |
| Oungsakul et al. | Candidate glycoprotein biomarkers for canine visceral hemangiosarcoma and validation using semi-quantitative lectin/immunohistochemical assays | |
| Lou et al. | Single cell expression and chromatin access of the Toxoplasma gondii lytic cycle identifies AP2XII-8 as an essential pivotal controller of a ribosome regulon | |
| Heuer et al. | Multiplex proteomic approaches to sepsis research: case studies employing new technologies | |
| López-Biedma et al. | Utility of Protein Markers in COVID-19 Patients | |
| Blume et al. | A multi-omics classifier achieves high sensitivity and specificity for pancreatic ductal adenocarcinoma in a case-control study of 146 subjects | |
| CN109804234A (zh) | 血液单元测试试剂盒 | |
| Ihm et al. | Chemiluminescent assay versus immunoblotting for detection of positive reaction to allergens | |
| CN120446499B (zh) | 蛋白标志物在制备2型糖尿病发病预测的试剂、试剂盒或装置中的应用 |